Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 crossover pharmacokinetic comparison of follitropin alfa from two manufacturing processes
NL-OMON58684Phase 1Completed
- Sponsor
- Merck KGaA
- Start
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of follitropin alfa in infertility (2 arms), sponsored by Merck KGaA. Primary endpoint: Primary pharmacokinetic endpoints. Started Mar 2024; status: completed.
02
Drugs
follitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NL-OMON58684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58684.